The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss

Abstract Introduction: It is difficult to evaluate the effect of drugs clinically used for idiopathic sudden sensorineural hearing loss, mainly because its underlying mechanism remains unknown. Objective: This study assessed the efficacy of hyperbaric oxygen therapy or ozone therapy in the treatme...

Full description

Bibliographic Details
Main Authors: Gülin Ergun Taşdöven, Alper Tunga Derin, Neslihan Yaprak, Hasan Ümit Özçağlar
Format: Article
Language:English
Published: Elsevier
Series:Brazilian Journal of Otorhinolaryngology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942017000400457&lng=en&tlng=en
id doaj-400e05141ace4d029aea605c50b1cb43
record_format Article
spelling doaj-400e05141ace4d029aea605c50b1cb432021-02-02T05:46:22ZengElsevierBrazilian Journal of Otorhinolaryngology1808-868683445746310.1016/j.bjorl.2016.06.002S1808-86942017000400457The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing lossGülin Ergun TaşdövenAlper Tunga DerinNeslihan YaprakHasan Ümit ÖzçağlarAbstract Introduction: It is difficult to evaluate the effect of drugs clinically used for idiopathic sudden sensorineural hearing loss, mainly because its underlying mechanism remains unknown. Objective: This study assessed the efficacy of hyperbaric oxygen therapy or ozone therapy in the treatment of idiopathic sudden sensorineural hearing loss, when either therapy was included with steroid treatment. Methods: A retrospective analysis examined 106 patients with idiopathic sudden sensorineural hearing loss seen between January 2010 and June 2012. Those with an identified etiology were excluded. The patients were divided into three treatment groups: oral steroid only (n = 65), oral steroid + hyperbaric oxygen (n = 26), and oral steroid + ozone (n = 17). Treatment success was assessed using Siegel criteria and mean gains using pre- and post-treatment audiograms. Results: The highest response rate to treatment was observed in the oral steroid + ozone therapy group (82.4%), followed by the oral steroid + hyperbaric oxygen (61.5%), and oral steroid groups (50.8%). There were no significant differences in the response to treatment between the oral steroid and oral steroid + hyperbaric oxygen groups (p < 0.355). The oral steroid + ozone group showed a significantly higher response rate to treatment than the oral steroid group (p = 0.019). There were no significant differences between the oral steroid + hyperbaric oxygen and oral steroid + ozone groups (p = 0.146). Conclusion: The efficiency of steroid treatment in patients with severe hearing loss was low. It was statistically ascertained that adding hyperbaric oxygen or ozone therapy to the treatment contributed significantly to treatment success.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942017000400457&lng=en&tlng=enOxigenoterapia hiperbáricaSurdez súbitaEsteroide oralOzonioterapia
collection DOAJ
language English
format Article
sources DOAJ
author Gülin Ergun Taşdöven
Alper Tunga Derin
Neslihan Yaprak
Hasan Ümit Özçağlar
spellingShingle Gülin Ergun Taşdöven
Alper Tunga Derin
Neslihan Yaprak
Hasan Ümit Özçağlar
The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss
Brazilian Journal of Otorhinolaryngology
Oxigenoterapia hiperbárica
Surdez súbita
Esteroide oral
Ozonioterapia
author_facet Gülin Ergun Taşdöven
Alper Tunga Derin
Neslihan Yaprak
Hasan Ümit Özçağlar
author_sort Gülin Ergun Taşdöven
title The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss
title_short The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss
title_full The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss
title_fullStr The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss
title_full_unstemmed The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss
title_sort place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss
publisher Elsevier
series Brazilian Journal of Otorhinolaryngology
issn 1808-8686
description Abstract Introduction: It is difficult to evaluate the effect of drugs clinically used for idiopathic sudden sensorineural hearing loss, mainly because its underlying mechanism remains unknown. Objective: This study assessed the efficacy of hyperbaric oxygen therapy or ozone therapy in the treatment of idiopathic sudden sensorineural hearing loss, when either therapy was included with steroid treatment. Methods: A retrospective analysis examined 106 patients with idiopathic sudden sensorineural hearing loss seen between January 2010 and June 2012. Those with an identified etiology were excluded. The patients were divided into three treatment groups: oral steroid only (n = 65), oral steroid + hyperbaric oxygen (n = 26), and oral steroid + ozone (n = 17). Treatment success was assessed using Siegel criteria and mean gains using pre- and post-treatment audiograms. Results: The highest response rate to treatment was observed in the oral steroid + ozone therapy group (82.4%), followed by the oral steroid + hyperbaric oxygen (61.5%), and oral steroid groups (50.8%). There were no significant differences in the response to treatment between the oral steroid and oral steroid + hyperbaric oxygen groups (p < 0.355). The oral steroid + ozone group showed a significantly higher response rate to treatment than the oral steroid group (p = 0.019). There were no significant differences between the oral steroid + hyperbaric oxygen and oral steroid + ozone groups (p = 0.146). Conclusion: The efficiency of steroid treatment in patients with severe hearing loss was low. It was statistically ascertained that adding hyperbaric oxygen or ozone therapy to the treatment contributed significantly to treatment success.
topic Oxigenoterapia hiperbárica
Surdez súbita
Esteroide oral
Ozonioterapia
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942017000400457&lng=en&tlng=en
work_keys_str_mv AT gulinerguntasdoven theplaceofhyperbaricoxygentherapyandozonetherapyinsuddenhearingloss
AT alpertungaderin theplaceofhyperbaricoxygentherapyandozonetherapyinsuddenhearingloss
AT neslihanyaprak theplaceofhyperbaricoxygentherapyandozonetherapyinsuddenhearingloss
AT hasanumitozcaglar theplaceofhyperbaricoxygentherapyandozonetherapyinsuddenhearingloss
AT gulinerguntasdoven placeofhyperbaricoxygentherapyandozonetherapyinsuddenhearingloss
AT alpertungaderin placeofhyperbaricoxygentherapyandozonetherapyinsuddenhearingloss
AT neslihanyaprak placeofhyperbaricoxygentherapyandozonetherapyinsuddenhearingloss
AT hasanumitozcaglar placeofhyperbaricoxygentherapyandozonetherapyinsuddenhearingloss
_version_ 1724302806330900480